These immune infiltrates likely create an anti-inflammatory microenvironment, which is in line with the fact that M2 macrophages outnumber M1 macrophages in nearly all types of sarcomas and that these tumor cells express CD47, which downregulates proinflammatory macrophage activity [191]. The gene discussed is CD47; the disease is neoplasm.